Mass General Brigham Research

What Mass General Brigham Research does

Mass General Brigham Research is the biomedical research division of Mass General Brigham, a nonprofit integrated healthcare system headquartered in Boston, Massachusetts. The research enterprise organizes the work of more than 3,700 Principal Investigators and 16,000 scientists across the system's academic medical centers, conducting studies in artificial intelligence and genomics, gene therapy, cancer, neuroscience, cardiovascular medicine, radiation oncology, and global health. Patient participation in clinical trials — typically delivered at no cost to eligible subjects — is a primary input into research, with outputs disseminated through peer-reviewed publication in journals such as Nature, Cell, and JAMA, and through the public-facing Bench Press blog and Science Insights discovery platform.

The organization's productized assets span four layers. First, communications and discovery: Bench Press (mgriblog.org) and Science Insights, the latter offering AI-powered personalized research recommendations. Second, philanthropic talent funding: the MGB Research Scholars program, which provides $500,000 in unrestricted funding over five years to early- and mid-career investigators and has supported 90+ scientists over 15 years. Third, applied AI and devices: AI-powered genomic analysis tools from the Karczewski Lab that decode DNA for disease diagnosis and rare-condition discovery; wearable robotic braces with machine-learning-driven adaptive support for ALS, stroke, and disability patients; implantable brain-computer interface (iBCI) work; single-neuron recording arrays; AI-augmented brain mapping at the Charlestown Navy Yard lab; and ambient AI scribes deployed in emergency medicine. Fourth, computational research tooling: TOP1-mediated DNA repair analysis, radiation therapy optimization models, and computer vision for cancer cell tracking.

The business model is nonprofit and grant- plus philanthropy-driven. Revenue streams include federal and foundation research grants (including NIH High Risk, High Reward awards), philanthropic gifts via [email protected], and intramural funding from the parent healthcare system; the firmographic employee count of 39 refers to the Bench Press editorial team rather than the broader research community. Go-to-market is community- and event-led: research is distributed through clinical trials, peer-reviewed publication, the Bench Press blog, monthly newsletters, and science engagement events, with customers functionally being patients, clinicians, and the global scientific community rather than commercial buyers.

Name

Mass General Brigham Research

Legal name

Mass General Brigham

Website

https://mgriblog.org

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

Mass General Brigham Research is the nonprofit biomedical research division of the Mass General Brigham healthcare system, coordinating 3,700+ Principal Investigators and 16,000 scientists across Boston-area academic medical centers in AI, genomics, cancer, neuroscience, and global health, funded through grants, philanthropy, and intramural support, with outputs disseminated via clinical trials, peer-reviewed publication, and the Bench Press platform.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Research & Science Grantmaking Foundations (BPAGAKAI)

Keywords

• Biomedical research
• Clinical trials
• Translational medicine
• Genomic analysis
• Neuroscience research

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Philanthropic Funding: The Mass General Brigham Research Scholars program is funded entirely through the support of visionary philanthropists. Each Scholar receives $500,000 in unrestricted funding over five years.
2. Research Grants: Funded through traditional grant mechanisms including NIH High Risk, High Reward Research Program and other governmental and foundation funding.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels8 records

Core offering

Mass General Brigham Research conducts biomedical research across AI, gene therapy, cancer, neuroscience, and global health through 212 active research programs. It operates the Bench Press research news platform and Science Insights discovery platform for public engagement, runs clinical trials that invite patient participation, and administers the MGB Research Scholars philanthropic funding program providing $500,000 over five years to early- and mid-career investigators.

Product overview

Mass General Brigham Research operates as a biomedical research institution with a community of over 3,700 Principal Investigators and 16,000 scientists. The organization offers several interconnected programs: Bench Press serves as the primary research news and communications platform; the MGB Research Scholars Program provides philanthropic funding for early-career investigators; Science Insights provides a discovery platform for research findings; and specialized research initiatives include AI-powered genomic analysis tools and wearable robotics assistive device development. These offerings collectively support the organization's mission to advance medicine from bench to bedside across fields including AI, gene therapy, cancer, neuroscience, and global health.

Differentiator

Problem solved

Functional benefit

Brands

• Bench Press: The research news blog of Mass General Brigham featuring scientific discoveries and research updates
• MGB Research Scholars
• Mass General Brigham Neuroscience Institute

Products and services

• MGB Research Scholars Program

Quantifiable outcome

• 55 patents filed in the past year
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability12 records

Feature8 records

Partnerships

Six partnerships are on record, tiered major, core and flagship.

• BESTMED ConsortiummajorStrategic or Co-development Partner · 13 July 2026International research consortium analyzing electronic health records and insurance claims from U.S. adults with Type 2 diabetes. Collaboration with Cleveland Clinic on diabetes medication prescribing patterns study.
• Boston Children's HospitalcoreStrategic or Co-development Partner · 6 July 2026Collaborating institution on study examining somatic mutations in individual neurons in brains affected by ALS, FTD and AD.
• Harvard University / Harvard Medical SchoolcoreStrategic or Co-development Partner · 1 January 2026Multidisciplinary collaboration between Mass General Brigham and Harvard Medical School on wearable robotics project. Conor Walsh, PhD from Harvard University's lab developed the technology. Project includes physical therapists, researchers, engineers, and neurologists specialized in neurorehabilitation.
• Brigham and Women's HospitalcoreStrategic or Co-development Partner · 1 January 2026Part of Mass General Brigham system; founding hospital with long tradition of medical breakthroughs including first successful organ transplant.
• PETAL ConsortiumcoreStrategic or Co-development Partner · 17 December 2025First-of-its-kind global network of more than 100 investigators and 20 research sites leading breakthroughs in rare blood cancers.
• XPRIZE FoundationflagshipStrategic or Co-development Partner · 1 January 2025Brigham researchers advanced to next phase of XPRIZE Healthspan Competition with $250,000 award and chance to compete for $101 million grand prize.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mayo Clinic Research: Mayo Clinic is one of the largest nonprofit academic medical centers in the U.S. with a comparably broad biomedical research enterprise spanning AI, genomics, neuroscience, and oncology. Directly comparable in mission, scale, and integrated care-to-research model.
• MD Anderson Cancer Center Research: MD Anderson is the largest dedicated cancer research institution in the U.S. and a direct peer for MGB's oncology programs, particularly translational and clinical trial research.
• Memorial Sloan Kettering Cancer Center Research: MSK is one of the world's leading cancer research institutions, comparable to MGB's cancer programs and a relevant peer for high-impact oncology research output and clinical trial scale.
• Johns Hopkins Medicine Research: Johns Hopkins Medicine operates a research enterprise of similar scale and breadth, with major NIH funding, AI-driven research, and a strong translational pipeline. Direct peer in academic medical center biomedical research.
• Cleveland Clinic Research: Cleveland Clinic is a comparable nonprofit academic medical center with major research programs and a confirmed MGB partner through the BESTMED Consortium. Direct peer across biomedical research, AI-driven medicine, and clinical innovation.
• Stanford Medicine Research: Stanford Medicine runs a top-tier biomedical research enterprise with deep AI, genomics, and bioengineering programs. Direct peer in academic biomedical research and a comparable convening institution for high-impact scientific talent.
• Penn Medicine Research: University of Pennsylvania's academic medical research enterprise, comparable in scale and focus across gene therapy, oncology, and translational medicine. Direct peer within the integrated academic medical center model.
• UCSF Health Research: UCSF operates a leading biomedical research enterprise with strengths in neuroscience, genomics, and AI-driven medicine. Direct peer in academic medical center research with comparable NIH funding intensity.

Broad incumbents

• Howard Hughes Medical Institute: HHMI is a major biomedical research organization supporting Investigator-led research at leading U.S. universities, comparable in mission to fund high-risk biomedical research. Serves as a peer in research funding scale and scientific influence.

Regional players

• Dana-Farber Cancer Institute: Dana-Farber is a Boston-based cancer research powerhouse and natural regional peer for MGB's oncology research. Operates in the same geography and frequently co-publishes and co-runs clinical trials with MGB.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/MGBResearchNews
• YouTubeyoutube.com/channel/UC0wwsnpCkdk-bgwV8h5XOGg
• LinkedInlinkedin.com/company/mgbresearch
• Instagraminstagram.com/mgbresearch

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mass General Brigham Research